JSM Activities Sponsored By
Biopharmaceutical Section*


The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2002 Program page



There were 221 records found
Activity Title Sponsor Type Date
Time
2002-02C Design and Analysis of Quality of Life Studies in Clinical Trials Biopharmaceutical Section*, ASA Other
Continuing Ed
08/10/2002
8:00 AM to 4:00 PM
3 * ! Statistical Data Stewardship in the 21st Century Cmte on Privacy and Confidentiality, Section on Statistical Consulting*, Section on Survey Research Methods*, Social Statistics Section*, Section on Government Statistics*, Section on Health Policy Statistics*, Biopharmaceutical Section* Invited
Papers
08/11/2002
2:00 PM to 3:50 PM
15 Design and Analysis of Gene Expression Microarray Experiments ENAR, Biometrics Section*, Section on Physical & Engineering Sciences*, Biopharmaceutical Section* Contributed
Papers
08/11/2002
2:00 PM to 3:50 PM
17 * ! Modeling in Time and Space Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/11/2002
2:00 PM to 3:50 PM
21 * Applications in Neurology and Cardiology Biometrics Section*, ENAR, Biopharmaceutical Section*, Section on Risk Analysis* Contributed
Papers
08/11/2002
2:00 PM to 3:50 PM
22 Diagnostic Testing and ROC Analysis Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/11/2002
2:00 PM to 3:50 PM
23 * Analytical Strategies in Clinical Trials Biopharmaceutical Section*, Biometrics Section*, ENAR Contributed
Papers
08/11/2002
2:00 PM to 3:50 PM
27 Analysis of Microarray Data Biometrics Section*, Biopharmaceutical Section*, ENAR, WNAR, Section on Risk Analysis* Invited
Papers
08/11/2002
4:00 PM to 5:50 PM
34 * Analysis Databases Biopharmaceutical Section* Topic Contributed
Papers
08/11/2002
4:00 PM to 5:50 PM
35 * Statisticial Issues with Medical Devices Biopharmaceutical Section*, Biometrics Section*, ENAR Topic Contributed
Papers
08/11/2002
4:00 PM to 5:50 PM
51 Models for Longitudinal Data Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/11/2002
4:00 PM to 5:50 PM
200485 Biopharmaceutical Section Executive Committee (closed) Biopharmaceutical Section* Other
Cmte/Business
08/12/2002
8:00 AM to 12:00 PM
59 * Quality of Life Data: Issues Related to Assessment and Analysis ENAR, Biometrics Section*, Biopharmaceutical Section*, Section on Health Policy Statistics* Invited
Papers
08/12/2002
8:30 AM to 10:20 AM
64 * ! Practical Aspects of Adaptive Designs in Clinical Trials Biopharmaceutical Section*, Biometrics Section*, ENAR Topic Contributed
Papers
08/12/2002
8:30 AM to 10:20 AM
79 Methods of Estimation for Censored Data Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/12/2002
8:30 AM to 10:20 AM
80 Categorical Data Methods Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/12/2002
8:30 AM to 10:20 AM
81 Analysis of Microarray Data Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/12/2002
8:30 AM to 10:20 AM
82 * Approches for Missing Data Biopharmaceutical Section*, Biometrics Section*, ENAR Contributed
Papers
08/12/2002
8:30 AM to 10:20 AM
87 Global Sensitivity Analysis in Missing Data -- Some Examples Biometrics Section*, ENAR, Biopharmaceutical Section* Invited
Papers
08/12/2002
10:30 AM to 12:20 PM
92 * Issues Relating to Crossover Trials Biopharmaceutical Section*, Biometrics Section*, ENAR Topic Contributed
Papers
08/12/2002
10:30 AM to 12:20 PM
93 * ! Determining the Statistical Significance of Observed Changes in Gene Expression Data Section on Statistical Computing*, Biometrics Section*, ENAR, Biopharmaceutical Section* Topic Contributed
Papers
08/12/2002
10:30 AM to 12:20 PM
110 * Clinical Trial Design and Monitoring Biometrics Section*, ENAR, Biopharmaceutical Section*, Section on Risk Analysis* Contributed
Papers
08/12/2002
10:30 AM to 12:20 PM
111 * Evaluating Gene Expression Data Biopharmaceutical Section*, Biometrics Section*, ENAR Contributed
Papers
08/12/2002
10:30 AM to 12:20 PM
126 Roundtable Luncheons (Fee Events) Biopharmaceutical Section* Luncheons
Roundtable Lnch
08/12/2002
12:30 PM to 1:50 PM
2002-20C Introduction to Molecular Biology and Bioinformatics Studies for Analysts Biopharmaceutical Section*, ASA Other
Continuing Ed
08/12/2002
1:00 PM to 5:00 PM
129 * ! Adaptive Sample-Size Considerations in the Presence of Unknown Treatment Effect and Nuisance Parameters Biopharmaceutical Section*, International Indian Statisticial Association, WNAR Invited
Papers
08/12/2002
2:00 PM to 3:50 PM
141 * ! Beyond the Simple Average: Adjusting for Heterogeneity and Bias in Meta-Analysis Section on Health Policy Statistics*, Biometrics Section*, ENAR, Biopharmaceutical Section* Topic Contributed
Papers
08/12/2002
2:00 PM to 3:50 PM
152 Issues in HIV Studies Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/12/2002
2:00 PM to 3:50 PM
155 * Issues in Drug Development Biopharmaceutical Section*, ENAR Contributed
Papers
08/12/2002
2:00 PM to 3:50 PM
158 Statistical Issues in Cost-effectiveness Analysis Biometrics Section*, Biopharmaceutical Section*, Section on Health Policy Statistics*, ENAR Invited
Papers
08/13/2002
8:30 AM to 10:20 AM
161 * Bayesian Analyses of Clinical Safety Data Section on Bayesian Stat. Sciences*, Biometrics Section*, Section on Health Policy Statistics*, ENAR, Biopharmaceutical Section* Invited
Papers
08/13/2002
8:30 AM to 10:20 AM
166 * Innovative Statistical Methods for Drug Discovery, Development and Safety Studies Biopharmaceutical Section*, ENAR Topic Contributed
Papers
08/13/2002
8:30 AM to 10:20 AM
185 * Issues in Clinical Pharmacology Biopharmaceutical Section* Contributed
Papers
08/13/2002
8:30 AM to 10:20 AM
191 * ! Experimental Design and Dimension Reduction in Gene Expression (Microarray) Data (Chemometrics Session) Section on Physical & Engineering Sciences*, Biopharmaceutical Section*, Biometrics Section* Invited
Papers
08/13/2002
10:30 AM to 12:20 PM
194 * Statistical Applications in Marketing Section on Statistics and Marketing, Biopharmaceutical Section*, Business & Economics Statistics Section* Invited
Papers
08/13/2002
10:30 AM to 12:20 PM
196 What Goes Into Making Clinical Trials Reliable? Biometrics Section*, ENAR, Biopharmaceutical Section* Topic Contributed
Papers
08/13/2002
10:30 AM to 12:20 PM
198 * Equivalence Testing Beyond Two Treatment Groups Biopharmaceutical Section*, ENAR Topic Contributed
Papers
08/13/2002
10:30 AM to 12:20 PM
213 * Data Analysis in Clinical Trials Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/13/2002
10:30 AM to 12:20 PM
214 * Survival Analysis Biopharmaceutical Section*, ENAR Contributed
Papers
08/13/2002
10:30 AM to 12:20 PM
215 Regular Contributed Posters Biometrics Section*, General Methodology, Section on Bayesian Stat. Sciences*, Biometrics Section*, Biopharmaceutical Section*, Section on Statistics in Epidemiology*, Section on Statistics & the Environment*, Section on Government Statistics*, ENAR, Section on Statistical Graphics*, Section on Risk Analysis* Contributed
Posters
08/13/2002
12:00 PM to 1:50 PM
231 Roundtable Luncheons (Fee Events) Biopharmaceutical Section* Luncheons
Roundtable Lnch
08/13/2002
12:30 PM to 1:50 PM
2002-26C Statistical Methods for Microarray Studies Biopharmaceutical Section*, ASA Other
Continuing Ed
08/13/2002
1:00 PM to 5:00 PM
233 * ! Statistical Methods in Pharmacogenomics Biopharmaceutical Section*, ENAR, Biometrics Section* Invited
Papers
08/13/2002
2:00 PM to 3:50 PM
258 Understanding Microarray Data Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/13/2002
2:00 PM to 3:50 PM
260 * Incomplete Data in Longitudinal Studies Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/13/2002
2:00 PM to 3:50 PM
200499 Biopharmaceutical Section Business Meeting Biopharmaceutical Section* Other
Cmte/Business
08/13/2002
5:30 PM to 7:00 PM
263 * ! Risk Assessment in an Era of Technology Change Section on Risk Analysis*, ENAR, Business & Economics Statistics Section*, Section on Health Policy Statistics*, Biopharmaceutical Section* Invited
Papers
08/14/2002
8:30 AM to 10:30 AM
264 * ! Computational Aspects of Medical and Pharmaceutical Statistics International Indian Statisticial Assoc, Reps. For Young Statisticians, Section on Health Policy Statistics*, ENAR, Biometrics Section*, Biopharmaceutical Section* Invited
Papers
08/14/2002
8:30 AM to 10:20 AM
283 * Bayes Analysis of Microarray Data Section on Bayesian Stat. Sciences*, Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/14/2002
8:30 AM to 10:20 AM
288 Modeling Survival Data Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/14/2002
8:30 AM to 10:20 AM
291 * Innovative Designs for Clinical Trials Biopharmaceutical Section*, Biometrics Section*, ENAR Contributed
Papers
08/14/2002
8:30 AM to 10:20 AM
293 * ! Statistical Methods in Cost-Effectiveness Analysis Section on Health Policy Statistics*, Biometrics Section*, Biopharmaceutical Section* Invited
Papers
08/14/2002
10:30 AM to 12:20 PM
294 * ! Data Mining Techniques in Drug Discovery and Development Biopharmaceutical Section*, SPAIG Committee, Section on Health Policy Statistics*, WNAR, ENAR Invited
Papers
08/14/2002
10:30 AM to 12:20 PM
320 Which Method to Use? Biopharmaceutical Section* Contributed
Papers
08/14/2002
10:30 AM to 12:20 PM
321 Regular Contributed Posters Section on Physical & Engineering Sciences*, Biometrics Section*, General Methodology, Biopharmaceutical Section*, Section on Nonparametric Statistics*, Section on Statistical Computing*, Section on Statistical Education*, Section on Quality & Productivity*, ENAR, Section on Risk Analysis* Contributed
Posters
08/14/2002
12:00 PM to 1:50 PM
335 Roundtable Luncheons (Fee Events) Biopharmaceutical Section* Luncheons
Roundtable Lnch
08/14/2002
12:30 PM to 1:50 PM
341 ! Beyond Intention to Treat: New Methodology for Estimating Treatment Effects in Clinical Trials ENAR, Biometrics Section*, Biopharmaceutical Section* Invited
Papers
08/14/2002
2:00 PM to 3:50 PM
346 Statistical Analysis of Gene Expression Data Biopharmaceutical Section*, Biometrics Section*, ENAR Topic Contributed
Papers
08/14/2002
2:00 PM to 3:50 PM
351 * ! Statistical Methods for Quality of Life IMS, Section on Government Statistics*, ENAR, Biopharmaceutical Section* Topic Contributed
Papers
08/14/2002
2:00 PM to 3:50 PM
364 * Issues in Fitting Models Biopharmaceutical Section*, Biometrics Section*, ENAR Contributed
Papers
08/14/2002
2:00 PM to 3:50 PM
367 * ! Statistics in Brain Mapping Biopharmaceutical Section*, ENAR, Biometrics Section*, Section on Statistical Graphics* Invited
Papers
08/15/2002
8:30 AM to 10:30 AM
373 * ! Assessing Differential Gene Expression from Microarray Studies Section on Statistical Computing*, Biometrics Section*, ENAR, Biopharmaceutical Section* Topic Contributed
Papers
08/15/2002
8:30 AM to 10:20 AM
387 ! Genomics and Proteomics Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/15/2002
8:30 AM to 10:20 AM
389 * Statistical Issues in Drug Discovery and Pre-Clinical Development Biopharmaceutical Section*, ENAR Contributed
Papers
08/15/2002
8:30 AM to 10:20 AM
394 * ! Data Mining Gene Expression Microarrays Section on Quality & Productivity*, ENAR, Biometrics Section*, Biopharmaceutical Section* Invited
Papers
08/15/2002
10:30 AM to 12:20 PM
395 PI and DSMB Responsibilities in Randomized Clinical Trials Biometrics Section*, Biopharmaceutical Section* Invited
Panel
08/15/2002
10:30 AM to 12:20 PM
396 * ! Use of Simulation in Clinical Trials and Statistical Inference Biopharmaceutical Section*, Biometrics Section*, ENAR, Section on Statistical Computing* Topic Contributed
Papers
08/15/2002
10:30 AM to 12:20 PM
410 Microarrays: Clustering and Discrimination Biometrics Section*, ENAR, Biopharmaceutical Section* Contributed
Papers
08/15/2002
10:30 AM to 12:20 PM
  • A * preceding a session name means that the session is an applied session.
  • A ! preceding a session name means that the session reflects the JSM meeting theme.
JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002